Study Notes on Pediatric Kidney Transplantation Donor Considerations
Abstract
Overview of kidney transplant donor options for children with end-stage kidney disease (ESKD).
Highlights variability in global access to kidney transplantation.
Factors influencing deceased donor (DD) and living donor (LD) transplants.
Majority of children with ESKD receive adult-sized kidneys.
Expectations of multiple kidney transplants in a child's lifetime due to finite kidney survival.
Living donor transplants offer better long-term graft survival for children.
Discussion on paired kidney exchange for incompatible donors.
Importance of documenting donor history and matching processes.
Introduction
Kidney transplantation is the optimal treatment for ESKD, significantly enhancing quality of life and survival rates.
Growing disparity between organ supply and demand leads to a search for expanded donor options.
Historical context of kidney transplantation and advancements in immunosuppressive therapies improving graft survival since the 1990s.
1-year graft survival rates for children under 5 years improved from 60-70% in the 1980s to higher rates today.
Chronic rise in ESKD cases globally over the last two decades questions healthcare resource allocation and cultural biases.
Global Access to Kidney Transplants
Estimates indicate <10% of children with kidney failure receive renal replacement therapy.
Inequities noted in access to kidney transplants, especially in children.
Data highlights that chronic renal replacement therapy is unavailable in 5% of countries.
Statistics on Waiting Lists in the USA
Current estimates: ~90,000 patients on the waiting list, ~20,000 transplants annually.
Kids under 18: 900-1,000 added to the waiting list yearly; about 1,500 currently waitlisted.
Transplant stats: ~750 children under 18 receive transplants yearly, 450-500 from DD.
Congenital kidney anomalies represent the primary cause of ESKD in impacted children.
Preemptive kidney transplantation occurs in only 15-25% of cases.
Types of Donor Sources
Living Donors (LD)
LD provides superior long-term survival when compared to DD.
In the USA, the half-life for DD is 12.3 years and LD is 15.3 years.
Countries with strong organ procurement systems see higher DD rates; LD is more common where organ donation lacks priority.
Optimal age and gender considerations for donor longevity: young and male donors are favorable.
Children prioritized on the waiting list; average waiting time for DD is 6-12 months for children versus 3-5 years for adults.
Deceased Donors (DD)
Can present dilemmas regarding donor selection and timing for transplantation.
Pediatric nephrologists face decisions on the potential for living vs. deceased donor organ availability.
Pediatric Considerations in Transplantation
Adult-sized Kidneys
Adult kidneys are frequently used for children due to size-matching difficulties; better outcomes typically result from adult-sized organs.
Children below 10 kg can still receive adult kidneys in some centers.
Risks associated with size mismatch leading to complications like abdominal compartment syndrome and hypoperfusion injury.
Pediatric Living Donors
Traditionally underutilized; parental donors predominantly the source.
Low rates of sibling donation; more emphasis is on unrelated donors in some regions.
Long-term survival shows advantages even with poor HLA matching in LD.
Guidelines from the American Academy of Pediatrics emphasize factors for considering minor donors.
Donor Types and Policies
Deceased Donor Policies
Varied allocation systems globally; Spain's 'opt out' policy exemplifies high donor rates.
USA operates an 'opt in' system, maintaining high numbers through given individual consent.
Risks Associated with Donor Types
Standard Criteria Donor (SCD): Young, healthy donors contribute to better outcomes.
Extended Criteria Donor (ECD): Older, possibly comorbid donors may also be considered.
Donation After Circulatory Death (DCD): Important for donor pool expansion, characterized by specific warm ischemia guidelines.
Pairing and Exchange Options
Paired kidney exchange is introduced as a mechanism to improve donor compatibility.
Enables swapping between incompatible pairs to create opportunities for compatible matches.
Develops logistics for decentralized and international kidney exchange programs.
Transplant Outcomes and Challenges
Graft Loss and Delayed Function
Graft loss risk of 25% within 7 years after transplant; primary non-function counts as a significant complication particularly in DCD kidneys.
Infection Risks from Donor Organs
Serious consideration of donor-derived infections requires thorough pre-transplant screening and ongoing follow-up after transplantation.
Importance of vaccination before transplant and ongoing risk evaluation for recipients.
Conclusion
Children facing kidney transplantation today often require several transplants throughout their lives.
Better awareness of organ donation and improved preservation techniques are necessary to address ongoing challenges in ESKD management.
Call for advancements in immunosuppressive strategies to aid long-term success in transplanted kidneys for pediatric patients.